Deficiencia de magnesio en enfermos de SQM
Publicado: 27 Sep 2012, 15:02
Teniendo en cuenta que es Rea el que firma el artículo, creo que vale la pena echar un vistazo. Él mismo advierte que los resultados son discretos, pero puede servir a algunos pacientes.
[t]Magnesium Deficiency In Patients With Chemical Sensitivity[/t]
William J. Rea, MD, FACS, Alfred R. Johnson, DO, Ralph E. Smiley, MD, Barbara Maynard, RD, Ollie Dawkins-Brown, MEd, MS
Abstract
Assessment of magnesium status in 51 consecutive chemically sensitive patients (12 males, 39 females, ages ranged from 13 to 67 years) in an environmentally controlled hospital unit was undertaken. The purpose of this study was to evaluate the magnesium status in chemically sensitive patients whose disorders were closely associated with the symptoms of magnesium deficiency. The symptoms included back and neck pain, fine tremors, muscle spasm, anxiety and nervousness, spastic vascular phenomena, ventricular arrhythmia, and fatigue. Results of laboratory tests and IV magnesium challenges showed that some patients with chemical sensitivities may have a disturbance of intracellular magnesium. RBC and plasma levels proved to be poor indicators of magnesium status: 2.8% (1/35 positive) and 15% (5/33 positive) respectively. Intravenous magnesium challenge appeared to be a more accurate assessment of total body magnesium status (76% positive 39/51). Overall clinical improvement with magnesium treatment appears to be somewhat low, (45% or 23 of 51) but it is worthy of consideration in those chemically sensitive patients who are magnesium deficient.
enlace al estudio completo: http://www.aehf.com/articles/A27.htm" onclick="window.open(this.href);return false;
[t]Magnesium Deficiency In Patients With Chemical Sensitivity[/t]
William J. Rea, MD, FACS, Alfred R. Johnson, DO, Ralph E. Smiley, MD, Barbara Maynard, RD, Ollie Dawkins-Brown, MEd, MS
Abstract
Assessment of magnesium status in 51 consecutive chemically sensitive patients (12 males, 39 females, ages ranged from 13 to 67 years) in an environmentally controlled hospital unit was undertaken. The purpose of this study was to evaluate the magnesium status in chemically sensitive patients whose disorders were closely associated with the symptoms of magnesium deficiency. The symptoms included back and neck pain, fine tremors, muscle spasm, anxiety and nervousness, spastic vascular phenomena, ventricular arrhythmia, and fatigue. Results of laboratory tests and IV magnesium challenges showed that some patients with chemical sensitivities may have a disturbance of intracellular magnesium. RBC and plasma levels proved to be poor indicators of magnesium status: 2.8% (1/35 positive) and 15% (5/33 positive) respectively. Intravenous magnesium challenge appeared to be a more accurate assessment of total body magnesium status (76% positive 39/51). Overall clinical improvement with magnesium treatment appears to be somewhat low, (45% or 23 of 51) but it is worthy of consideration in those chemically sensitive patients who are magnesium deficient.
enlace al estudio completo: http://www.aehf.com/articles/A27.htm" onclick="window.open(this.href);return false;